Rapid Aortic Measurements vs TeraRecon Aorta.CT

When choosing between Rapid Aortic Measurements by iSchemaView (RapidAI) and TeraRecon Aorta.CT, physicians should consider their primary use case and existing infrastructure. Rapid Aortic Measurements excels in comprehensive, automated analysis and longitudinal tracking of aortic disease. It provides 24 guideline-based measurements and 3D reconstructions from all CT scan types, including post-treatment and non-contrast studies, making it suitable for ongoing patient surveillance and detailed anatomical change monitoring.

TeraRecon Aorta.CT, on the other hand, focuses on automatic 3D segmentation and anatomical landmark labeling specifically from CT Angiography scans. Its strength lies in aiding procedure planning and patient management by providing DICOM result files for integration with other DICOM-compliant systems. The key practical difference is RapidAI’s broader analytical scope and ability to process diverse CT scan types for long-term management, versus TeraRecon’s specialized focus on CTA for procedural planning.

Physicians prioritizing extensive automated measurements, 3D reconstructions, and longitudinal tracking across various CT scan types for aortic disease management should lean towards Rapid Aortic Measurements. Those primarily needing automated aortic segmentation and landmark labeling from CT Angiography for procedure planning and seamless integration into existing DICOM workflows may find TeraRecon Aorta.CT a more direct fit. Both are FDA-cleared and HIPAA compliant, with flexible deployment options.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist